对清细胞癌晚期复发的预后因素的评估:一项机构研究

Diana Voskuil-Galoş1, Tudor Călinici2, Andra Piciu1,3

  • 1Department of Medical Oncology, The Oncology Institute Prof. Dr. Ion Chiricuţă, Cluj-Napoca, Romania.

Frontiers in oncology
|October 22, 2024
PubMed
概括

非转移性细胞癌 (nmRCC) 的晚期复发是常见的. 预后因素如IMDC得分和Fuhrman等级影响生存率,表明需要在手术后对患者进行延长的随访.